BioHarvest Sciences has taken significant steps to bolster its Contract Development and Manufacturing Organization (CDMO) Services Business Unit by announcing the appointment of two key figures in the biotechnology and pharmaceutical industries. Matt Zrebiec, with over two decades of experience in the pharmaceutical sector, has been named Vice President of Business Development. His role will focus on identifying and securing new business opportunities, leveraging his extensive background in branded specialty, biotech, generics, and CDMO pharmaceutical sectors to drive the company's growth.
In a parallel development, Professor Itay Mayrose has been appointed as Senior Artificial Intelligence Scientist. Professor Mayrose is celebrated for his contributions to plant computational genomics and his innovative use of artificial intelligence in genome editing and evolutionary studies. His work, which has been published in leading scientific journals such as Nature and Science, positions him as a pivotal figure in advancing BioHarvest Sciences' research and development efforts.
Ilan Sobel, CEO of BioHarvest Sciences, highlighted the strategic importance of these appointments, emphasizing the company's dedication to innovation and excellence within the CDMO Services Business Unit. By integrating the expertise of Zrebiec and Mayrose, BioHarvest Sciences aims to accelerate its strategic objectives and enhance value for its stakeholders, reinforcing its position as a leader in the biotechnology industry.
